We are live on ! Find out more
IDNA icon

iShares Genomics Immunology and Healthcare ETF
IDNA

84 hedge funds and large institutions have $98.7M invested in iShares Genomics Immunology and Healthcare ETF in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 31 increasing their positions, 15 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 15

63% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 8

15% more capital invested

Capital invested by funds: $85.8M → $98.7M (+$12.8M)

6% more funds holding

Funds holding: 79 → 84 (+5)

0.6% more ownership

Funds ownership: 26.83% → 27.44% (+0.6%)

Holders
84
Holders Change
+5
Holders Change %
+6.33%
% of All Funds
1.46%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
13
Increased
31
Reduced
15
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCS
Retirement Capital Strategies
California
+$3.97M
2
WBG
Wharton Business Group
Pennsylvania
+$2.07M
3
CPC
Congress Park Capital
New York
+$1.02M
4
WAP
Wealthcare Advisory Partners
Pennsylvania
+$962K
5
Morgan Stanley
Morgan Stanley
New York
+$929K

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$8.21M
2
OWA
Outlook Wealth Advisors
Texas
-$747K
3
Bank of America
Bank of America
North Carolina
-$353K
4
FTUS
Flow Traders U.S.
New York
-$336K
5
Cetera Investment Advisers
Cetera Investment Advisers
Illinois
-$247K
Name Holding Trade Value Shares
Change 		Change in
Stake
LNC
26
Lincoln National Corp
Pennsylvania
$792K -$107K -2,286 -13%
Stifel Financial
27
Stifel Financial
Missouri
$712K +$50.1K +1,067 +8%
VWA
28
Visionary Wealth Advisors
Illinois
$575K +$17.7K +377 +4%
RJFSA
29
Raymond James Financial Services Advisors
Florida
$534K +$23.9K +510 +5%
Osaic Holdings
30
Osaic Holdings
Arizona
$523K +$19.8K +421 +4%
CAN
31
Cetera Advisor Networks
California
$511K +$5.73K +122 +1%
IFG
32
Independent Financial Group
California
$496K +$95.5K +2,034 +27%
FHC
33
First Heartland Consultants
Missouri
$462K -$329 -7 -0.1%
Northern Trust
34
Northern Trust
Illinois
$390K – – –
IWM
35
IHT Wealth Management
Illinois
$369K -$103K -2,194 -24%
Carson Wealth (CWM LLC)
36
Carson Wealth (CWM LLC)
Nebraska
$359K – – –
NGA
37
Naples Global Advisors
Florida
$352K – – –
Nomura Asset Management
38
Nomura Asset Management
Japan
$328K – – –
ASN
39
Advisory Services Network
Georgia
$308K +$282 +6 +0.1%
SPC
40
Sigma Planning Corp
Michigan
$293K -$16.1K -344 -6%
FTUS
41
Flow Traders U.S.
New York
$285K -$336K -7,152 -57%
GSEP
42
Golden State Equity Partners
California
$285K +$257K +5,474 New
PFGIA
43
Patriot Financial Group Insurance Agency
Massachusetts
$283K +$246K +5,245 +2,805%
TWM
44
Tolleson Wealth Management
Texas
$278K – – –
JIR
45
James Investment Research
Ohio
$273K – – –
MML Investors Services
46
MML Investors Services
Massachusetts
$267K +$240K +5,123 New
OC
47
Oppenheimer & Co
New York
$261K +$236K +5,020 New
WCM
48
Wealthcare Capital Management
Virginia
$258K +$92.1K +1,962 +65%
FFN
49
Focus Financial Network
Minnesota
$249K – – –
CFO
50
CVA Family Office
Colorado
$222K +$200K +4,264 New
1
2
3 4

IDNA Hedge Fund Activity: Q2 2021 in Review

84 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in iShares Genomics Immunology and Healthcare ETF (IDNA) for Q2 2021, worth a combined $98.7M — up 15% from $85.8M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new IDNA positions and 8 closed out — a net gain of 5 holders — while 31 added to existing stakes and 15 trimmed.

The largest buyer was Retirement Capital Strategies, adding an estimated $3.97M. The largest seller was Jane Street, cutting an estimated $8.21M.

  • 84 institutional investors held iShares Genomics Immunology and Healthcare ETF (IDNA) as of Q2 2021, up from 79 in Q1 2021.
  • Funds reported $98.7M of iShares Genomics Immunology and Healthcare ETF stock for Q2 2021, up 15% quarter-over-quarter.
  • 13 funds opened new iShares Genomics Immunology and Healthcare ETF positions in Q2 2021 and 8 closed out, a net change of +5 holders.
  • The largest iShares Genomics Immunology and Healthcare ETF buyer in Q2 2021 was Retirement Capital Strategies, an estimated $3.97M added.
  • The largest iShares Genomics Immunology and Healthcare ETF seller in Q2 2021 was Jane Street, an estimated $8.21M sold.

Based on aggregated 13F filings for Q2 2021.